Pneumology - Case Reports Open access

Metastatic mandibular ameloblastoma of the lung ten years after primary resection: A rare case report

Authors

Published
9 April 2021
Section
Pneumology - Case Reports
DOI
10.4081/monaldi.2021.1643

Abstract

Ameloblastoma is a rare odontogenic neoplasm of the jaw. It usually behaves as a benign, slow growing tumour of the oral cavity with a high recurrence rate, especially when it is inadequately resected. A small proportion of ameloblastomas metastasize to distant organs, with lungs representing the most common site of metastatic spread. In this report, we present the case of a middle-aged man with two pulmonary nodules and a history of mandibular ameloblastoma excised 10 years prior to this radiological finding. Following resection and histopathological analysis of the lung lesion, a diagnosis of metastatic ameloblastoma was confirmed. No local recurrence of the primary tumour was identified. At 1-year follow-up, the patient had no evidence of local or metastatic disease.

Keywords

References

  1. Oomens MA, Van der Waal I. Epidemiology of ameloblastomas of the jaws; a report from the Netherlands. Med Oral Patol Oral Cir Bucal 2014;19:e581-3. DOI: https://doi.org/10.4317/medoral.20316
  2. MacDonald-Jankowski DS, Yeung R, Lee KM, Li TK. Ameloblastoma in the Hong Kong Chinese. Part 2: systematic review and radiological presentation. Dentomaxillofac Radiol 2004;33:141-51. DOI: https://doi.org/10.1259/dmfr/28001874
  3. Nagi R, Sahu S, Rakesh N. Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update. J Oral Maxillofac Pathol 2016;20:497-504. DOI: https://doi.org/10.4103/0973-029X.190954
  4. Verneuil A, Sapp P, Huang C, Abemayor E. Malignant ameloblastoma: classification, diagnostic, and therapeutic challenges. Am J Otolaryngol 2002;23:44-8. DOI: https://doi.org/10.1053/ajot.2002.28769
  5. Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 2006;85:74. DOI: https://doi.org/10.1177/014556130608500201
  6. Van Dam SD, Unni KK, Keller EE. Metastasizing (malignant) ameloblastoma: review of a unique histopathologic entity and report of Mayo Clinic experience. J Oral Maxillofac Surg 2010;68:2962-74. DOI: https://doi.org/10.1016/j.joms.2010.05.084
  7. Laughlin EH. Metastasizing ameloblastoma. Cancer 1989;64:776-80. DOI: https://doi.org/10.1002/1097-0142(19890801)64:3<776::AID-CNCR2820640335>3.0.CO;2-8
  8. Jayaraj G, Sherlin HJ, Ramani P, et al. Metastasizing Ameloblastoma - a perennial pathological enigma? Report of a case and review of literature. J Craniomaxillofac Surg 2014;42:772-9. DOI: https://doi.org/10.1016/j.jcms.2013.11.009
  9. White RM, Patterson JW. Distant skin metastases in a long-term survivor of malignant ameloblastoma. J Cutan Pathol 1986;13:383-9. DOI: https://doi.org/10.1111/j.1600-0560.1986.tb00474.x
  10. Hayakawa K, Hayashi E, Aoyagi T, et al. Metastatic malignant ameloblastoma of the kidneys. Int J Urol 2004;11:424-6. DOI: https://doi.org/10.1111/j.1442-2042.2004.00822.x
  11. Nguyen BD. Malignant ameloblastoma with thoracic vertebral metastasis: PET/CT and MR imaging. Clin Nucl Med 2005;60:450-2. DOI: https://doi.org/10.1097/01.rlu.0000163382.16320.6b
  12. Azumi T, Nakajima T, Takeuchi S, et al. Malignant ameloblastoma with metastasis to the skull: report of case. J Oral Surg 1981;39:690-6.
  13. Vorzimer J, Perla D. An Instance of adamantinoma of the Jaw with Metastases to the Right Lung. Am J Pathol 1932;8:445-54.
  14. Rizzitelli A, Smoll NR, Chae MP, et al. Incidence and overall survival of malignant ameloblastoma. PLoS One 2015;10:e0117789. DOI: https://doi.org/10.1371/journal.pone.0117789
  15. Berger AJ, Son J, Desai NK. Malignant ameloblastoma: concurrent presentation of primary and distant disease and review of the literature. J Oral Maxillofac Surg 2012;70:2316-26. DOI: https://doi.org/10.1016/j.joms.2011.11.004
  16. Grünwald V, Le Blanc S, Karstens JH, et al. Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin. Ann Oncol 2001;12:1489-91. DOI: https://doi.org/10.1023/A:1012522929861
  17. Lanham RJ. Chemotherapy of metastatic ameloblastoma. A case report and review of the literature. Oncology 1987;44:133-4. DOI: https://doi.org/10.1159/000226461
  18. González-González R, López-Verdín S, Lavalle-Carrasco J, et al. Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review. World J Clin Oncol 2020;11:31-42. DOI: https://doi.org/10.5306/wjco.v11.i1.31
  19. Broudic-Guibert M, Blay JY, Vazquez L, et al. Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report. J Med Case Rep 2019;13:245. DOI: https://doi.org/10.1186/s13256-019-2140-6
  20. Hasim FW, Poon CC, Smith AC. Prolonged survival with confirmed metastatic pulmonary ameloblastoma. Int J Oral Maxillofac Surg 2007;36:953-5. DOI: https://doi.org/10.1016/j.ijom.2007.02.010

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2021 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.